AT&T stock price jumps nearly 4% as Verizon Communications buyback jolts telecom shares

AT&T stock price jumps nearly 4% as Verizon Communications buyback jolts telecom shares

NEW YORK, Jan 30, 2026, 14:17 (EST) — Regular session

AT&T Inc. (T) shares jumped 3.7%, hitting $26.06 by 2:17 p.m. EST on Friday. T-Mobile US added 4.0%, while Verizon surged 10.9%, buoyed by a wider rally in U.S. telecom stocks.

The rally coincides with investors digging into carrier earnings for signs of pricing power and cash returns following a holiday season packed with heavy promotions. Verizon forecast adjusted earnings of $4.90 to $4.95 per share for 2026, alongside at least $21.5 billion in free cash flow. The company also greenlit a $25 billion share buyback under new CEO Dan Schulman. On top of that, Verizon is expanding its broadband footprint after acquiring Frontier Communications. 1

Dallas-based AT&T laid out a long-term plan through 2028 on Wednesday, focusing on fiber and 5G bundles while shifting to a new reporting format starting in Q1. The company predicts adjusted earnings of $2.25 to $2.35 per share in 2026 and free cash flow topping $18 billion—cash remaining after capital expenditures. It also aims to buy back roughly $8 billion in stock that year and maintain its $1.11 per share annual dividend. Net debt to adjusted EBITDA is expected to climb to about 3.2 times post-deals, then drop to around 3 times by the end of 2026. “With new investments in spectrum and fiber, we’re set to win more customers,” said CEO John Stankey. 2

AT&T posted fourth-quarter adjusted earnings of 52 cents per share on $33.5 billion in revenue, topping analysts’ 46-cent forecast, Investors Business Daily reported. The telecom giant gained 421,000 postpaid phone subscribers—those who pay monthly bills. It also added 283,000 fiber internet customers, noting that 42% of fiber households bundle its wireless service. 3

The strategy hinges on two deals in the pipeline: roughly a $6 billion acquisition of Lumen Technologies’s consumer fiber division, plus a $23 billion pact to buy spectrum licenses from EchoStar—the frequencies carriers use to handle mobile data. Stankey noted the Lumen assets are expected to enable reaching “over 40 million customer locations” with fiber by the end of the year. 4

Deutsche Bank’s Bryan Kraft bumped his AT&T price target to $33 from $31 on Thursday, maintaining a buy rating following the company’s latest update. His note focused more on the three-year outlook rather than the typical quarterly subscriber chatter. 5

Doubts linger over a potential wireless price war, and any pricing misstep could quickly boost churn—the rate at which customers depart. Oppenheimer & Co. lowered its price target to $29 from $32, pointing to rising churn and more aggressive promotions as signs the “price war” is already underway. 6

Investors are focused on those transactions closing on time and how they’ll impact spending and debt once integration kicks off. AT&T has indicated it expects both deals to wrap up early this year. 7

AT&T’s next quarterly dividend is set for Feb. 2, despite the record date already being behind us. Traders are eager for fresh updates or filings that clarify the closing dates for the Lumen and EchoStar transactions. 8

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
New York, Feb 7, 2026, 09:39 EST — Market closed. Apple Inc (AAPL.O) shares ended Friday up 0.8% at $278.12 after swinging between $276.92 and $280.90, before dipping 0.3% in after-hours trading. U.S. markets are shut on Saturday, but the stock goes into Monday with a familiar question back on the tape: will Apple raise iPhone prices, or eat higher costs. 1 The immediate pressure point is memory. A tightening supply of DRAM — the memory chips that help phones run power-hungry apps smoothly — is pushing up component costs just as investors are re-pricing the economics of the broader
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
Shopify stock slides 7% as rate jitters return; here’s what traders watch next
Previous Story

Shopify stock slides 7% as rate jitters return; here’s what traders watch next

TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying
Next Story

TTM Technologies stock jumps as Raytheon’s $200 million deal and S&P MidCap 400 move stir buying

Go toTop